First-Line and Neoadjuvant Immunotherapy for Gastric Cancer

Clinical trial NCT06727981 · RECRUITING

Trial details

NCT number: NCT06727981
Sponsor: Qilu Hospital of Shandong University
Status: RECRUITING
Study type: OBSERVATIONAL

Advanced Gastric Cancer Locally Advanced Gastric Carcinoma

Start date: 2022-01-15
Primary completion: 2027-01-15
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.